Abstract
Infection with dengue virus has increased its importance due to the growth of population and has positioned itself as the most important arbovirus worldwide. Two cases of Guillain Barre syndrome are described, which occurred in the department of Huila in the second half of 2013 and which was detected as a causal agent of acute dengue virus infection by indirect evidence (Dengue IgM). The first case had a typical presentation and the second an atypical presentation; we found that neurological manifestations produced by this virus are still poorly understood, and in endemic regions it should be suspected and actively sought as an etiology of various neurological syndromes.
References
SANGUANSERMSRI T, PONEPRASERT B, PHORNPHUTKUL B, ET AL. Acute encephalopathy associated with dengue infection. Seameo Tropmed 1976:10-11.
GONZÁLEZ G, AMAYA E, VARGAS N. Características clínicas, complicaciones y secuelas de pacientes con diagnóstico de encefalitis en el Hospital Universitario Hernando Moncaleano Perdomo - junio a noviembre del año 2013. Acta Neurol Colomb 2014; 3 (Aprobado para publicación el 20/6/14).
MELGAR CE, GONZÁLEZ G. Complicaciones neurológicas de la infección por virus del dengue. Acta Neurol Colomb 2007; 23:259-265
GONZÁLEZ G, BENAVIDES A, FERNÁNDEZ J. Manifestaciones Neurológicas del Dengue. Revista Chilena de Neuro-Psiquiatria 2003; 41 :18 - 19.
PUCCIONI-SOHLER M, ORSINI M, SOARES C. Dengue: a new challenge for neurology. Neurology International 2012; 4:e15.
SOARES CN, FARIA LC, PUCCIONI-SOHLER M, PERALTA JM, FREITAS MRG. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci 2006;249:19-24.
LANDRY O. Nore sur la paralysie ascendante aigue. Gaz Hebd Med Paris 1859;6: 472-4.
PAUL C, DUPONT B, PIALOUX G. Polyradiculonévrite aiguë secondaire à une dengue. Presse Med 1990;19:1503.
SULEKHA C, KUMAR S, PHILIP J. Guillain-Barré syndrome following dengue fever: report of 3 cases. Indian Pediatr. 2004;41:948-50
GONCALVES E. Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome) following dengue fever. Rev. Inst. Med. Trop. Sao Paulo, 53(4): 223-5, 2011.
DIMACHKIE M, BAROHN RICHARD. Guillain-Barre Syndrome and Variants. Neurol Clin 2013; 31:492.
BAROHN RJ. Approach to peripheral neuropathy and neuronopathy. Sem Neurol 1998;18:7-18.
DIMACHKIE M, BAROHN RICHARD. Guillain-Barre Syndrome and Variants. Neurol Clin 2013;31: 494.
RODRÍGUEZ J. Manifestaciones neurológicas del dengue. Acta Neurol Colomb 2008; 24(1): Supp.1
WHO-PAHO. Number of reported cases of Dengue and Severe Dengue in the Americas Week 6 2014.
Instituto Nacional de Salud. SIVIGILA. Boletín Epidemiológico Semana 5 2014.
Boletín epidemiológico Dengue: Semana Epidemiológica 5 de 2014. Departamento del Huila
SANTOS NQ, AZOUBEL AC, LOPES AA, COSTA G, BACELLAR A. Guillain-Barré syndrome in the course of dengue: case report. Arq Neuropsiquiatr 2004;62:144-146
Guía de atención clínica integral del Paciente con Dengue. Bogotá, 2010. Ministerio de la Protección Social. Instituto Nacional de Salud
ARAÚJO FMC, ARAÚJO MS, NOGUEIRA RMN, BRILHANTE RSN, OLIVEIRA DN, ROCHA MFG, CORDEIRO RA, ARAÚJO RMC, SIDRIM JJC: Central nervous system involvement in dengue: a study in fatal cases from a dengue endemic area. Neurology 2012, 78:736-742.
GONZALEZ G, AMAYA E, VARGAS N. Características clínicas, complicaciones y secuelas de pacientes con diagnóstico de encefalitis en el hospital universitario Hernando Moncaleano Perdomo - junio a noviembre del año 2013. Acta Neurol Colomb. 2014; 30(3): 163-168.
YUKI N, HARTUNG HP. Guillain-Barré syndrome. New Eng J of M. 2012;366:2294-2304.
LIN Y-S, ET AL. Molecular mimicry between virus and host and its implications for Dengue disease pathogenesis. Exp Biol Med 2011;236(5):515-523.
LIU IJ, CHIU CY, CHEN YC, WU HC. Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem 2011;286(11):9726-36.
SAITO M, OISHI K, INOUE S, DIMAANO EM, ALERA MT, ROBLES AM, ET AL. Association of increased platelet associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol. 2004;138:299-03.
DIMACHKIE M, BAROHN RICHARD. Guillain-Barre Syndrome and Variants. Neurol Clin 2013;31:498.
VAN DEN BERGH PY, PIE´RET F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004;29(4): 565-74.
HUGHES RA, WIJDICKS EF, BENSON E, ET AL. Multidisciplinary Consensus Group. Supportive care for patients with Guillain-Barre´ syndrome. Arch Neurol 2005; 62(8):1194-8.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.